NDE1 and bladder transitional cell carcinoma: Furthermore, we noted that there was also a trend that lower NDE1 expression levels were associated with longer OS or DFS in patients with BLCA, CESC, COAD, DLBC, KICH, KIRP, LUSC, PAAD, SARC and UVM, although no statistical significance was observed (Figure S1).